The 28‐year incidence of de novo malignancies after liver transplantation: A single‐center analysis of risk factors and mortality in 1616 patients
Open Access
- 7 June 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 23 (11) , 1404-1414
Abstract
De novo malignancies (DNMs) are one of the leading causes of late mortality after liver transplantation (LT). We analyzed 1616 consecutive patients who underwent LT between 1988 and 2006 at our institution. All patients were prospectively observed over a study period of 28 years by our own outpatient clinic. Complete follow‐up data were available for 96% of patients, 3% were incomplete, and only 1% were lost to follow‐up. The median follow‐up of the patients was 14.1 years. Variables with possible prognostic impact on the development of DNMs were analyzed, as was the incidence of malignancies compared with the nontransplant population by using standardized incidence ratios. In total, 266 (16.5%) patients developed 322 DNMs of the following subgroups: hematological malignancies (n = 49), skin cancer (n = 83), and nonskin solid organ tumors (SOT; n = 190). The probability of developing any DNM within 10 and 25 years was 12.9% and 23.0%, respectively. The respective probability of developing SOT was 7.8% and 16.2%. Mean age at time of diagnosis of SOT was 57.4 years (range, 18.3‐81.1 years). In the multivariate analysis, an increased recipient age (hazard ratio [HR], 1.03; P < 0.001) and a history of smoking (HR, 1.92; P < 0.001) were significantly associated with development of SOT. Moreover, the development of SOT was significantly increased in cyclosporine A–treated compared with tacrolimus‐treated patients (HR, 1.53; P = 0.03). The present analysis shows a disproportionate increase of de novo SOT with an increasing follow‐up period. Increased age and a history of smoking are confirmed as major risk factors. Moreover, the importance of immunosuppression is highlighted. Liver Transplantation 23 1404–1414 2017 AASLD.Keywords
This publication has 30 references indexed in Scilit:
- Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantationLiver Transplantation, 2011
- Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic reviewLiver International, 2010
- Increased Incidence of Early De Novo Cancer in Liver Graft Recipients Treated with Cyclosporine: An Association with C2 Monitoring and Recipient AgeLiver Transplantation, 2010
- Long-term Probability of and Mortality From De Novo Malignancy After Liver TransplantationGastroenterology, 2009
- Smoking Behavior in Liver Transplant RecipientsLiver Transplantation, 2009
- Liver Transplantation in the Ethnic Minority Population: Challenges and ProspectsDigestive Diseases and Sciences, 2009
- Liver transplantation and subsequent risk of cancer: Findings from a Canadian cohort studyLiver Transplantation, 2008
- De novo malignancies following liver transplantation: a case–control study with long‐term follow‐upClinical Transplantation, 2006
- De Novo Internal Neoplasms after Liver Transplantation: Increased Risk and Aggressive Behavior in Recent Years?American Journal of Transplantation, 2004
- Chinese Revenues and Systems of TaxationScience, 1886